Tags

Type your tag names separated by a space and hit enter

Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study.
BMC Infect Dis. 2019 Apr 27; 19(1):351.BI

Abstract

BACKGROUND

Middle East respiratory syndrome coronavirus (MERS-CoV) is considered to be responsible for a new viral epidemic and an emergent threat to global health security. This study describes the current epidemiological status of MERS-CoV in the world.

METHODS

Epidemiological analysis was performed on data derived from all MERS-CoV cases recorded in the disease outbreak news on WHO website between 1.1.2017 and 17.1.2018. Demographic and clinical information as well as potential contacts and probable risk factors for mortality were extracted based on laboratory-confirmed MERS-CoV cases.

RESULTS

A total of 229 MERS-CoV cases, including 70 deaths (30.5%), were recorded in the disease outbreak news on world health organization website over the study period. Based on available details in this study, the case fatality rate in both genders was 30.5% (70/229) [32.1% (55/171) for males and 25.8% (15/58) for females]. The disease occurrence was higher among men [171 cases (74.7%)] than women [58 cases (25.3%)]. Variables such as comorbidities and exposure to MERS-CoV cases were significantly associated with mortality in people affected with MERS-CoV infections, and adjusted odds ratio estimates were 2.2 (95% CI: 1.16, 7.03) and 2.3 (95% CI: 1.35, 8.20), respectively. All age groups had an equal chance of mortality.

CONCLUSIONS

In today's "global village", there is probability of MERS-CoV epidemic at any time and in any place without prior notice. Thus, health systems in all countries should implement better triage systems for potentially imported cases of MERS-CoV to prevent large epidemics.

Authors+Show Affiliations

Epidemiologist in Social Determinants of Health Research Center, Urmia University of Medical Sciences, Resalat Street, Urmia, Iran.Epidemiologist in Social Determinants of Health Research Center, Urmia University of Medical Sciences, Resalat Street, Urmia, Iran. ahmadzadeh.j@umsu.ac.ir.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31029095

Citation

Mobaraki, Kazhal, and Jamal Ahmadzadeh. "Current Epidemiological Status of Middle East Respiratory Syndrome Coronavirus in the World From 1.1.2017 to 17.1.2018: a Cross-sectional Study." BMC Infectious Diseases, vol. 19, no. 1, 2019, p. 351.
Mobaraki K, Ahmadzadeh J. Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study. BMC Infect Dis. 2019;19(1):351.
Mobaraki, K., & Ahmadzadeh, J. (2019). Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study. BMC Infectious Diseases, 19(1), 351. https://doi.org/10.1186/s12879-019-3987-2
Mobaraki K, Ahmadzadeh J. Current Epidemiological Status of Middle East Respiratory Syndrome Coronavirus in the World From 1.1.2017 to 17.1.2018: a Cross-sectional Study. BMC Infect Dis. 2019 Apr 27;19(1):351. PubMed PMID: 31029095.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study. AU - Mobaraki,Kazhal, AU - Ahmadzadeh,Jamal, Y1 - 2019/04/27/ PY - 2018/04/22/received PY - 2019/04/15/accepted PY - 2019/4/29/entrez PY - 2019/4/29/pubmed PY - 2019/6/20/medline KW - Case fatality rate KW - Descriptive epidemiology KW - Disease outbreak KW - Emerging diseases KW - Middle East respiratory syndrome coronavirus SP - 351 EP - 351 JF - BMC infectious diseases JO - BMC Infect Dis VL - 19 IS - 1 N2 - BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) is considered to be responsible for a new viral epidemic and an emergent threat to global health security. This study describes the current epidemiological status of MERS-CoV in the world. METHODS: Epidemiological analysis was performed on data derived from all MERS-CoV cases recorded in the disease outbreak news on WHO website between 1.1.2017 and 17.1.2018. Demographic and clinical information as well as potential contacts and probable risk factors for mortality were extracted based on laboratory-confirmed MERS-CoV cases. RESULTS: A total of 229 MERS-CoV cases, including 70 deaths (30.5%), were recorded in the disease outbreak news on world health organization website over the study period. Based on available details in this study, the case fatality rate in both genders was 30.5% (70/229) [32.1% (55/171) for males and 25.8% (15/58) for females]. The disease occurrence was higher among men [171 cases (74.7%)] than women [58 cases (25.3%)]. Variables such as comorbidities and exposure to MERS-CoV cases were significantly associated with mortality in people affected with MERS-CoV infections, and adjusted odds ratio estimates were 2.2 (95% CI: 1.16, 7.03) and 2.3 (95% CI: 1.35, 8.20), respectively. All age groups had an equal chance of mortality. CONCLUSIONS: In today's "global village", there is probability of MERS-CoV epidemic at any time and in any place without prior notice. Thus, health systems in all countries should implement better triage systems for potentially imported cases of MERS-CoV to prevent large epidemics. SN - 1471-2334 UR - https://www.unboundmedicine.com/medline/citation/31029095/Current_epidemiological_status_of_Middle_East_respiratory_syndrome_coronavirus_in_the_world_from_1_1_2017_to_17_1_2018:_a_cross_sectional_study_ L2 - https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3987-2 DB - PRIME DP - Unbound Medicine ER -